The Impact of Needle-Exchange Programs on the Spread of HIV among Injection Drug Users: A Simulation Study

Journal of Urban Health

Volumn 80, Issue 2, 2003, Pages 302-320

  Raboud, J M ^a,b,g   Boily, M C ^c   Rajeswaran, J ^d   O'Shaughnessy, M V ^e   Schechter, M T ^f  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g MOUNT SINAI HOSPITAL   (Canada)

Author keywords

HIV transmission; Injection drug user; Monte Carlo simulation; Needle exchange program

Indexed keywords

ARTICLE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MONTE CARLO METHOD; NEEDLE; PRIORITY JOURNAL; VIRUS TRANSMISSION; CANADA; DISEASE TRANSMISSION; DRUG ABUSE; EVALUATION; HEALTH CARE QUALITY; PREVENTIVE HEALTH SERVICE; SUBSTANCE ABUSE; VIROLOGY;

BRITISH COLUMBIA; HIV INFECTIONS; HUMANS; MONTE CARLO METHOD; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; PROGRAM EVALUATION; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0041977270     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: 10.1093/jurban/jtg033     Document Type: Article

References (47)

1. Bardsley J, Turvey J, Blatherwick J. Vancouver's needle exchange program. Can J Public Health. 1990;81:39-45.
2. Hartgers C, Van Ameijden EJ, van den Hoek JA, Coutinho RA. Needle sharing and participating in the Amsterdam syringe exchange programme among HIV seronegative injecting drug users. Public Health Rep. 1992;107:675-681.
3. Kaplan EH. Needle exchange or needless exchange? The state of the debate. Infect Agents Dis. 1992;1:92-98.
4. Des Jarlais DC, Paone D, Friedman SR, Peyser N, Newman RG. Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs. Am J Public Health. 1995;85:1577-1584.
5. Needle-exchange programmes in the USA: time to act now [editorial]. Lancet. 1998;351:75.
6. Bruneau J, Lamothe F, Franco E, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol. 1997;146:994-1002.
7. Archibald CP, Ofner M, Strathdee SA, et al. Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada. J Acquir Immun Defic Syndr Hum Retrovirol. 1998;17:160-166.
8. Hahn JA, Vranizan KM, Moss AR. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. J Acquir Immun Defic Syndr Hum Retrovirol. 1997;15:157-164.
9. Miller CL, Tyndall M, Spittal P, et al. Risk-taking behaviours among injecting drug users who obtain syringes from pharmacies, fixed sites and mobile van needle exchanges. J Urban Health. 2002;79:257-265.
10. Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Soc Sci Med. 2000;51:1771-1782.
11. Valente TW, Foreman RK, Junge B, Vlahov D. Needle-exchange participation, effectiveness, and policy: syringe relay, gender and the paradox of public health. J Urban Health. 2001;78:340-349.
12. Lurie P, Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet. 1997;349:604-608.
13. Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet. 1997;349:1797-1800.
14. Laufer FN. Cost-effectiveness of syringe exchange as an HIV prevention strategy. J Acquir Immune Defic Syndr. 2001;28:273-278.
15. Makulowich GS. Cost effectiveness of SEPs. AIDS Patient Care STDs. 1998;12:151-152.
16. Manzon L, Rosario M, Rekart ML. HIV seroprevalence among street involved Canadians in Vancouver. AIDS Educ Prev. Fall 1992;suppl:86-89.
17. Harvey E, Strathdee SA, Patrick DM, et al. A qualitative investigation into an HIV outbreak among injection drug users in Vancouver, British Columbia. AIDS Care. 1998;10:313-321.
18. Strathdee SA, Patrick DM, Currie S, et al. Needle exchange is not enough: lessons from the Vancouver injection drug use study. AIDS. 1997;11:F59-F65.
19. Burns SM, Brettle RP, Gore SM, Peutherer JF, Robertson JR. The epidemiology of HIV infection in Edinburgh related to the injecting of drugs: an historical perspective and new insight regarding the past incidence of HIV infection derived from retrospective HIV antibody testing of stored samples of serum. J Infect. 1996;32:53-62.
20. Rhodes T, Ball A, Stimson GV, et al. HIV infection associated with drug injecting in the newly independent states, eastern Europe: the social and economic context of epidemics. Addiction. 1999;94:1323-1336.
21. Choopanya K, Vanichseni S, Des Jarlais DC, et al. Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS. 1991;5:1509-1513.
22. Des Jarlais DC, Friedman SR, Choopanya K, Vanichseni S, Ward TP. International epidemiology of HIV and AIDS among injecting drug users. AIDS. 1992,6:1053-1068.
23. Kaplan EH. Needles that kill: modelling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. Rev Inf Dis. 1989;11:289-298.
24. Greenhalgh D, Hay G. Mathematical modelling of the spread of HIV/AIDS amongst injecting drug users. IMA J Math Appl Med Biol. 1997;14:11-38.
25. Atkinson J. A simulation model of the dynamics of HIV transmission in intravenous drug users. Computers Biomed Res. 1996;29:338-349.
26. Peterson D, Willard K, Altmann M, Gatewood L, Davidson G. Monte Carlo simulation of HIV infection in an intravenous drug user community. J Acquir Immun Defic Syndr. 1990;3:1086-1095.
27. Kretzschmar M, Wiessing LG. Modelling the spread of HIV in social networks of IVDU. AIDS. 1998;12:801-811.
28. Iannelli M, Milner FA, Pugliese A, Gonzo M. The HIV/AIDS epidemics among drug injectors: a study of contact structure through a mathematical model. Math Biosci. 1997;139:25-58.
29. Allard R. A mathematical model to describe the risk of infection from sharing injection equipment. J Acquir Immune Defic Syndr. 1990;3:1010-1016.
30. Kaplan EH. Economic analysis of needle exchange. AIDS. 1995;9:1113-1119.
31. Anthony JC, Vlahov D, Nelson KE, Cohn S, Astemborski J, Solomon L. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am J Epidemiol. 1991;134:1175-1189.
32. Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande M, Moss AR. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA. 1989;261:561-565.
33. Guadagnino V, Zimatore G, Izzi A, et al. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy. J Clin Lab Immunol. 1995;47:1-9.
34. Clark SJ, Saag MS, Decker WD, et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med. 1991;324:954-960.
35. Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med. 1991;324:961-964.
36. Schacker TW, Hughes J, Shea T, Coombs RW, Corey L. Biological and virological characteristics of primary HIV infection. Ann Intern Med. 1998;128:613-620.
37. Wall SD, Olcott EW, Gerberding JL. AIDS risk and risk reduction in the radiology department. Am J Roentgenol. 1991;157:911-917.
38. Kaplan EH, Heimer R. A model-based estimate of HIV infectivity via needle-sharing. J Acquir Immune Defic Syndr. 1992;5:1116-1118.
39. Galli M, Musicco M. Mortality of intravenous drug users living in Milan, Italy: role of HIV-1 infection. COMCAT Study Group. AIDS. 1994;8:1457-1463.
40. Schechter MT, Strathdee SA, Cornelisse PGA, et al. Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. AIDS. 1999;13:F45-F51.
41. Guenter CD, Fonseca K, Nielson DM, Wheeler VJ, Pim CP. HIV prevalence remains low among Calgary's needle exchange program participants. Can J Public Health. 2000;91:129-132.
42. Des Jarlais DC. Research, politics and needle-exchange. Am J Public Health. 2000;90:1392-1394.
43. Jacobs P, Calder P, Taylor M, Houston S, Saunders LD, Albert T. Cost effectiveness of Streetworks' needle exchange program of Edmonton. Can J Public Health. 1999;90:168-171.
44. Laurie ML, Green KL. Health risks and opportunities for harm reduction among injection drug using clients of Saskatoon's needle-exchange programs. Can J Public Health. 2000;91:350-352.
45. Monterroso ER, Hamburger ME, Vlahov D, et al. Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS). J Acquir Immune Defic Syndr. 2000;25:63-70.
46. Rich JD, Foisie CK, Towe CK, McKensie M, Salas CM. High street prices of syringes correlate with strict syringe possession laws. Am J Drug Alcohol Abuse. 2000;26:481-487.
47. Taussig JA, Weinstein B, Burris S, Jones TS. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. AIDS. 2000;14(suppl 1):S47-S51.